Ashland Financial Results
Ashland Inc. reported fourth quarter fiscal 2026 sales of $498 million, a 4% increase year-over-year driven by volume growth in Life Sciences and Personal Care. The company reported a net loss of $16 million for the quarter but generated $121 million in Adjusted EBITDA and $74 million in ongoing free cash flow.
- Term
- Q4 2026
“Ashland closed fiscal 2026 with strong commercial performance across our higher-growth Life Sciences and Personal Care businesses, as well as coatings and performance specialties within Specialty Additives, and improved profitability in Intermediates.”
Guillermo Novo, chair and chief executive officer, Ashland
“Our priorities are clear: improve operating performance, drive productivity across our network, maintain pricing discipline, build on our commercial momentum and continue to scale our globalize and innovate initiatives.”
Guillermo Novo, chair and chief executive officer, Ashland